CME Group price target raised to $257 from $231 at Barclays

Barclays raised the firm’s price target on CME Group (CME) to $257 from $231 and keeps an Equal Weight rating on the shares. The macro backdrop looks constructive going into 2025 for the brokers, asset managers and exchanges, the analyst tells investors in a research note. The firm is increasingly constructive on the alternative asset managers, where an “unleash” of transacting has been growing and looks set to happen, and brokers, where it sees healthy earnings growth opportunities.